Latest Sofinnova Stories
Co-founder Sharon Barkai to Explore Recent Trends in Open-Source for Software Defined Networking Mountain View, Calif.
-- Funding to Expand Global Sales and Marketing, and Support Research and Development for Existing Products and Cancer Monitoring -- SAN CARLOS, Calif., April 6, 2015 /PRNewswire/
Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on April 13th and 14th for Cancer Advance Boston, a networking conference of the Boston Biotech Conference
Funds to Support Continued Adoption of FirstStepDx PLUS and NextStepDx PLUS Tests for Pediatric Development Disorders SALT LAKE CITY, Feb.
Former InterMune CEO Brings Deep Biotech Expertise and Operational Leadership to High Performing Team MENLO PARK, Calif., Jan.
Proceeds Will Be Used to Advance Clinical Programs in Growth Hormone Deficiency and Pulmonary Arterial Hypertension COPENHAGEN, Denmark, Dec.
Genetic Rx Boston Boston, MA (PRWEB) November
New Fund to Invest in Healthcare Products, Diagnostics, Devices, Consumer/OTC Health and Healthcare IT MENLO PARK, Calif., Aug.
SVP IX fund to invest primarily in late-stage biopharmaceutical companies MENLO PARK, Calif., July 23, 2014 /PRNewswire/ -- Sofinnova Ventures, a Menlo Park based investment firm, today
MADRID, July 16, 2014 /PRNewswire/ -- Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile
- A serpent whose bite was fabled to produce intense thirst.